FDA Approves Weight-Loss Drug Belviq (WSJ): After years of delays, Arena Pharmaceuticals’ lorcaserin, to be marketed as Belviq and distributed by Eisai Co., will be the first new drug treatment for weight loss in more than a decade.

Vaccine Shows Promise for Nicotine Addiction (WSJ): In a study published in Science Translational Medicine, researchers kept most of the nicotine given to mice from reaching their brains by inserting a gene for a nicotine antibody into their liver cells.

OxyContin Maker Guards Exclusivity (WSJ): Purdue Pharma is trying to extend its exclusive rights to the powerful and heavily abused painkiller, which is scheduled to go off patent next year.

Early Menopause Tied to Higher Heart Disease Risk (Reuters): A study of health surveys of more than 2,500 women published in the journal Menopause found going through menopause before age 46 made women about twice as likely to suffer heart attacks or strokes than women who hit it later.

No Bath Salts in Face Chewer’s System, Tests Show (Los Angeles Times): A Florida man shot and killed by police as he gnawed on a homeless man’s face had marijuana in his system — but not other street drugs, prescription drugs or alcohol, according to toxicology report. There had been widespread speculation that the man might have consumed “bath salts” — the commonly used name for a relatively new and potent street drug.

Latest Skin-Care Buzz: Bee Venom (WSJ): The venom is being touted as a “natural Botox” that stimulates the body’s production of collagen and elastin to smooth and tighten skin.